Physicians weigh in on malpractice, patient gifts, romantic relationships, and more in Medscape’s latest survey. Medscape Medical News
Tag: News
In Gene Therapy for RP, LCA, the Earlier, the Better
A real-world study of an FDA-approved gene therapy for inherited retinal disease shows younger patients gain more visual improvements than adults, but doesn’t rule out the procedure for the older people. Medscape Medical News
Medicare Will Speed Coverage of Some ‘Breakthrough’ Devices
CMS intends to speed payment decisions for as many as five “breakthrough” medical devices a year, potentially getting them to patients earlier. Medscape Medical News
Real-World Results Show Sustainability, Safety of Faricimab
Early results of a real-world study of faricimab demonstrated sustainable improvements in visual acuity and retinal anatomic markers with no new safety concerns. Medscape Medical News
Aflibercept for ROP Shows Sustained Efficacy at Age 3
Myopia was less common and less severe in patients who received aflibercept than in patients who received laser photocoagulation, a study shows. Medscape Medical News
Eyelid Imaging Could Aid Early Diagnosis of Sjögren Disease
Patients with Sjögren disease had more damage to their oil-producing Meibomian glands than people with other varieties of dry eye. Medscape Medical News
Parkinson’s Drug May Delay Onset of Wet AMD
L-dopa, a common Parkinson’s disease treatment, could reduce the burden of frequent injections for patients with wet AMD by delaying disease progression. Medscape Medical News
First Combined Face and Eye Transplant Performed
The successful operation, which previously had been considered impossible, may point toward the next stage of vision restoration. Medscape Medical News
Gene Therapy Shown to Improve Vision in Congenital Blindness
In an early phase trial, gene therapy showed an ability to restore function to rods and cones as well as functional vision decades after the onset of blindness. Medscape Medical News
Viridian Says Thyroid Eye Disease Drug Effective in Reducing Symptoms
Viridian Therapeutics said on Tuesday its experimental drug to treat patients with thyroid eye disease significantly reduced symptoms in a late-stage study, sending its… Reuters Health Information
Viridian’s Drug Cuts Thyroid Eye Disease Symptoms in Late-stage Study
Viridian Therapeutics said on Tuesday its experimental treatment helped significantly reduce symptoms of thyroid eye disease (TED) in a late-stage study, setting the stage… Reuters Health Information
New Insights into Management of Sjögren-Related Lymphoma
Two European studies reported on a potentially strong predictive biomarker for marginal lymphoma in Sjögren disease and the effectiveness of systemic therapy vs localized treatment or watch and wait. Medscape Medical News
Public Funding for Cataract Surgery Helped Wealthy Patients
Early results indicate that a policy change meant to expand access to cataract surgery in Ontario has fallen short, researchers said. Medscape Medical News
Introducing Paid for Peer Navigators for Serious Illness
New Medicare codes will enable physicians to hire navigators to help patients manage serious illnesses such as cancer and heart failure. Medscape Medical News
Introducing Paid-For Peer Navigators for Serious Illness
New Medicare codes will enable physicians to hire navigators to help patients manage serious illnesses such as cancer and heart failure. Medscape Medical News
Cigna to Remove AbbVie’s Humira From Some Drug Reimbursement Lists Next Year
Cigna said on Monday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement in 2025, and recommend… Reuters Health Information
Research Promises Better Diabetic Retinopathy Management
Exploring risk factors and promising new treatments might slow the progression of diabetic retinopathy. Medscape Medical News
Vision Loss a Dementia Risk Factor? What Do the Data Say?
A recent Lancet report claims nearly half of dementia cases could be prevented by addressing 14 risk factors, including vision loss. But is this recommendation backed by evidence? Let’s explore Medscape Medical News
Study Highlights Antibiotics Linked to Severe Skin Reactions
Compared with macrolides, sulfonamides were most strongly associated with serious cutaneous reactions. Medscape Medical News
Retinal Treatments Don’t Just Cost the Price on the Package
Ophthalmologists need more wiggle room from insurers to determine the best treatment for their patients based on a drug’s cost, its expected impact, and the person’s circumstances. Medscape Medical News